Norman L. Foster

发表

Characterizing Alzheimer's disease using a hypometabolic convergence index

Paul M. Thompson, et al., Clifford R. Jack, 2011, NeuroImage.

Adaptive Markov modeling for mutual-information-based, unsupervised MRI brain-tissue classification

Suyash P. Awate, Ross T. Whitaker, Tolga Tasdizen, 2006, Medical Image Anal..

Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: Findings from the Alzheimer's Disease Neuroimaging Initiative

Michael W. Weiner, Paul M. Thompson, Danielle J. Harvey, 2010, NeuroImage.

Automatic classification of Alzheimer’s Disease vs. Frontotemporal dementia: A spatial decision tree approach with FDG-PET

Tolga Tasdizen, Norman L. Foster, Satoshi Minoshima, 2008, 2008 5th IEEE International Symposium on Biomedical Imaging: From Nano to Macro.

Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI)

et al., Gene E. Alexander, Michael Weiner, 2009, NeuroImage.

Quantifying Metabolic Asymmetry Modulo Structure in Alzheimer's Disease

P. Thomas Fletcher, Sarang C. Joshi, Stephanie Powell, 2007, IPMI.

Multivariate and univariate neuroimaging biomarkers of Alzheimer's disease

Yaakov Stern, Christian G. Habeck, Norman L. Foster, 2008, NeuroImage.

MRI Tissue Classification with Neighborhood Statistics: A Nonparametric, Entropy-Minimizing Approach

Suyash P. Awate, Ross T. Whitaker, Tolga Tasdizen, 2005, MICCAI.

An accurate and computationally efficient method for voxel-by-voxel estimation of the Pittsburgh compound B distribution volume ratio

Michael W. Weiner, Daniel Bandy, William J. Jagust, 2008 .

IC-P2-128: Twelve-month cerebral metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment: Preliminary findings from the Alzheimer's disease neuroimaging initiative

Michael W. Weiner, Gene E. Alexander, Kewei Chen, 2008, Alzheimer's & Dementia.

Clinical use of amyloid-positron emission tomography neuroimaging: Practical and bioethical considerations

Norman L. Foster, Adam S. Fleisher, Gil D. Rabinovici, 2015, Alzheimer's & dementia.

Consensus report of the working group on: 'Molecular and biochemical markers of Alzheimer's disease'

Giovanni B. Frisoni, Alfredo Robles, Takeshi Iwatsubo, 1998 .

A 30-Week Randomized Controlled Trial of High-Dose Tacrine in Patients With Alzheimer's Disease

Gastone G. Celesia, David A. Bennett, Norman L. Foster, 1994 .

The influence of biological and technical factors on quantitative analysis of amyloid PET: Points to consider and recommendations for controlling variability in longitudinal data

Lennart Thurfjell, Norman L. Foster, Robert A. Koeppe, 2015, Alzheimer's & Dementia.

O1-02-06: Twelve-month cerebral metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment: Preliminary findings from the Alzheimer's disease neuroimaging initiative (ADNI)

Michael W. Weiner, Gene E. Alexander, Kewei Chen, 2008, Alzheimer's & Dementia.

Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association

Peter Herscovitch, Nicolaas I. Bohnen, Norman L. Foster, 2013, Alzheimer's & Dementia.

The Use of MRI and PET for Clinical Diagnosis of Dementia and Investigation of Cognitive Impairment : A Consensus Report

William J. Jagust, Ronald C. Petersen, Norman L. Foster, 2004 .

Adaptive, Nonparametric Markov Modeling for Unsupervised, MRI Brain-Tissue Classification

Suyash P. Awate, Ross T. Whitaker, Tolga Tasdizen, 2006 .